1. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes 
Robert W. Schrier, Raymond O. Estacio, Anne Esler, Philip Mehler 
Kidney International 
Volume 61, Issue 3, Pages (March 2002)
DOI: /j x
Copyright © 2002 International Society of Nephrology Terms and Conditions

2. Figure 1 Design and patient follow up rates for the ABCD Trial.
Kidney International  , DOI: ( /j x)
Copyright © 2002 International Society of Nephrology Terms and Conditions

3. Figure 2
Mean systolic(A) and diastolic (B) blood pressures ± standard errors according to intensive (solid line) versus moderate (dashed line) therapy throughout 5 years. T tests at each time interval revealed a significant and persistent blood pressure separation occurred after 6 months between the two interventions, P <
Kidney International  , DOI: ( /j x)
Copyright © 2002 International Society of Nephrology Terms and Conditions

4. Figure 3
Mean total cholesterol (normal range 130 to 200 mg/dL) and glycosylated hemoglobin (normal range 4.2 to 7.0%) values ± standard errors over 5-years for the intensive (solid line) versus moderate (dashed line) therapy (A), and nisoldipine (solid line) versus enalapril (dashed line) therapy(B). T tests at each time interval reveal no significant difference between the therapies.
Kidney International  , DOI: ( /j x)
Copyright © 2002 International Society of Nephrology Terms and Conditions

5. Figure 4
Mean creatinine clearances ± standard errors according to (A) intensive (solid line) versus moderate (dashed line) blood pressure control and (B) nisoldipine (solid line) versus enalapril (dashed line).
Kidney International  , DOI: ( /j x)
Copyright © 2002 International Society of Nephrology Terms and Conditions

6. Figure 5
Mean creatinine clearances ± standard errors according to intensive (solid line) versus moderate (dashed line) therapy for patients with normoalbuminuria (A) and microalbuminuria (B) at baseline.
Kidney International  , DOI: ( /j x)
Copyright © 2002 International Society of Nephrology Terms and Conditions

7. Figure 6
Log urinary albumin excretion (UAE) for intensive (solid line) and moderate (dashed line) blood pressure control groups: (A) normoalbuminuria at baseline; (B) microalbuminuria at baseline. *T test performed at various time intervals revealed a P value <0.05.
Kidney International  , DOI: ( /j x)
Copyright © 2002 International Society of Nephrology Terms and Conditions

8. Figure 7
Kaplan-Meier curves demonstrating progression from normoalbuminuria to microalbuminuria (A; P = 0.04) and from microalbuminuria to overt albuminuria (B; P = 0.02 )in patients on (solid line) intensive versus (dashed line) moderate therapy.
Kidney International  , DOI: ( /j x)
Copyright © 2002 International Society of Nephrology Terms and Conditions